Back

Type I interferons govern Zika virus resistance of human macrophages and microglia

Hanrath, A. T.; Hatton, C. F.; Gothe, F.; Browne, C.; Vowles, J.; Leary, P.; Cockell, S. J.; Cowley, S. A.; James, W. S.; Hambleton, S.; Duncan, C. J. A.

2022-03-11 cell biology
10.1101/2022.03.09.483671 bioRxiv
Show abstract

The role of the human type I interferon (IFN-I) system in restricting Zika virus (ZIKV) is uncertain. Here, genetic and pharmacological ablation of IFN-I signalling enhanced ZIKV replication and cytopathicity in macrophages and microglia, key cells in ZIKV transmission and pathogenesis. Thus, despite the extensive IFN-I countermeasures employed by ZIKV, IFN-I dictates the outcome of infection in macrophages. Therapeutic manipulation of the IFN-I system may bring clinical benefit in ZIKV.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.